Hanimune Therapeutics

Provider of food allergy therapeutics development and education services

placePhiladelphia, Pennsylvania, United States calendar_todayFounded 2018 language hanimunetherapeutics.com

Investor mix

1 investor on record.

Investor typeCountShare
Venture capital1100%
Coming soon